Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  HIV Infection

  Free Subscription


15.03.2021

22 AIDS
6 AIDS Res Hum Retroviruses
2 Antivir Ther
2 Blood
7 Clin Infect Dis
1 Int J Cancer
2 J Infect Dis
2 J Med Virol
1 J Virol
1 Lancet Infect Dis
1 MMWR Morb Mortal Wkly Rep
1 Nature
1 Pediatr Infect Dis J
1 Pediatrics
12 PLoS One
1 PLoS Pathog


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    AIDS

  1. CONNOLLY S, Carlson JM, Schaefer M, Bere A, et al
    HLA-associated preadaptation in HIV Vif is associated with higher set point viral load and faster CD4 decline in Zambian transmission pairs.
    AIDS. 2021 Mar 10. pii: 00002030-900000000-96459.
    PubMed         Abstract available

  2. TAPIA GR, Glynn TR, Miller C, Manuzak JA, et al
    Syndemics and pre-exposure prophylaxis are independently associated with rectal immune dysregulation in sexual minority men.
    AIDS. 2021 Mar 10. pii: 00002030-900000000-96460.
    PubMed         Abstract available

  3. WANG Z, Manion MM, Laidlaw E, Rupert A, et al
    Redistribution of brain glucose metabolism in people with HIV after antiretroviral therapy initiation.
    AIDS. 2021 Mar 11. pii: 00002030-900000000-96458.
    PubMed         Abstract available

  4. MORTON T, Chege W, Swann E, Senn TE, et al
    Advancing long-acting and extended delivery HIV prevention and treatment regimens through behavioral science: NIH workshop directions.
    AIDS. 2021 Mar 10. pii: 00002030-900000000-96457.
    PubMed        

  5. RIOS A
    Kaposi sarcoma: a fresh look.
    AIDS. 2021;35:515-516.
    PubMed        

  6. ROELOFSEN EE, Wildenbeest S, Mollema FP, Burger DM, et al
    Pharmacokinetics of tenofovir disoproxyl fumarate/emtricitabine in a client on pre-exposure prophylaxis after a total gastrectomy.
    AIDS. 2020;34:1989-1991.
    PubMed        

  7. LEVY JA, Coutinho RA, Saag MS
    AIDS new editor announcement.
    AIDS. 2020;34:1995.
    PubMed        

  8. YOTSUMOTO M, Hachiya A, Ichiki A, Amano K, et al
    Second-generation integrase strand inhibitors can be effective against elvitegravir-derived multiple integrase gene substitutions.
    AIDS. 2020 Sep 14. doi: 10.1097/QAD.0000000000002688.
    PubMed        

  9. YADAVA SK, Vyas V, Jain H, Fazili T, et al
    Thrombotic thrombocytopenic purpura associated with AIDS: challenges in diagnosis and management.
    AIDS. 2020;34:1101-1102.
    PubMed        

  10. ASHIGBIE PG, Laing RO, Wirtz VJ, Nkrumah N, et al
    Registration timelines of antiretroviral medicines in Ghana and Kenya.
    AIDS. 2020;34:1093-1095.
    PubMed         Abstract available

  11. MOUNZER K, Brunet L, Wyatt CM, Fusco JS, et al
    To dose-adjust or not to dose-adjust: 3TC dose in kidney impairment.
    AIDS. 2021 Mar 10. pii: 00002030-900000000-96461.
    PubMed         Abstract available

  12. VAN DEN HOF M, Jellema PEJ, Haar AMT, Scherpbier HJ, et al
    Normal structural brain development in adolescents treated for perinatally acquired HIV: A longitudinal imaging study.
    AIDS. 2021 Mar 8. pii: 00002030-900000000-96462.
    PubMed         Abstract available

  13. KAPETANOVIC S, Giganti MJ, Abzug MJ, Lindsey JC, et al
    Plasma biomarker factors associated with neurodevelopmental outcomes in children with perinatal HIV infection and controlled viremia.
    AIDS. 2021 Mar 11. pii: 00002030-900000000-96463.
    PubMed         Abstract available

  14. DALEL J, Ung SK, Hayes P, Black SL, et al
    HIV-1 infection and the lack of viral control are associated with greater expression of interleukin-21 receptor on CD8+ T cells.
    AIDS. 2021 Mar 11. pii: 00002030-900000000-96472.
    PubMed         Abstract available

  15. THIMM MA, Eke AC
    Tenofovir, pregnancy and renal function changes in pregnant women living with HIV.
    AIDS. 2021 Mar 11. pii: 00002030-900000000-96471.
    PubMed         Abstract available

  16. DEJONG C, Spinelli MA, Okochi H, Gandhi M, et al
    Tenofovir-based PrEP for COVID-19: an untapped opportunity?
    AIDS. 2021 Mar 11. pii: 00002030-900000000-96470.
    PubMed        

  17. BULSTRA CA, Reddy CL, Atun R, Barnighausen T, et al
    Impact of the COVID-19-related global recession on the financing of the global HIV response.
    AIDS. 2021 Mar 11. pii: 00002030-900000000-96469.
    PubMed        

  18. FRENCH AL, Grennan D, Daubert E, Seaberg EC, et al
    Decreases in markers of monocyte/macrophage activation after hepatitis C eradication in HIV/HCV co-infected women.
    AIDS. 2021 Mar 11. pii: 00002030-900000000-96468.
    PubMed         Abstract available

  19. NICKOLAS TL, Barasch J, Mugwanya KK, Branch AD, et al
    Kidney injury biomarkers during exposure to tenofovir-based pre-exposure prophylaxis.
    AIDS. 2021 Mar 11. pii: 00002030-900000000-96467.
    PubMed         Abstract available

  20. MERCURIO V, Fitzgerald W, Vanpouille C, Molodtsov I, et al
    Mechanisms of residual immune activation in HIV-1 infected human lymphoid tissue ex vivo.
    AIDS. 2021 Mar 11. pii: 00002030-900000000-96466.
    PubMed         Abstract available

  21. TAKAHASHI N, Ardeshir A, Holder GE, Cai Y, et al
    Comparison of predictors for terminal disease progression in SIV/SHIV-infected rhesus macaques.
    AIDS. 2021 Mar 11. pii: 00002030-900000000-96465.
    PubMed         Abstract available

  22. DAVY-MENDEZ T, Napravnik S, Eron JJ, Cole SR, et al
    Racial, ethnic, and gender disparities in hospitalizations among persons with HIV in the United States and Canada, 2005-2015.
    AIDS. 2021 Mar 11. pii: 00002030-900000000-96464.
    PubMed         Abstract available


    AIDS Res Hum Retroviruses

  23. LOFGREN SM, Nicol MR, Kandole TK, Castillo-Mancilla JR, et al
    A Descriptive Analysis of Dried Blood Spot Adherence Testing Among Ugandans with HIV Presenting with Cryptococcal Meningitis.
    AIDS Res Hum Retroviruses. 2021 Mar 7. doi: 10.1089/AID.2020.0202.
    PubMed         Abstract available

  24. RUDOMETOVA NB, Shcherbakova NS, Shcherbakov DN, Mishenova EV, et al
    Genetic diversity and drug resistance mutations in reverse transcriptase and protease genes of HIV-1 isolates from Southwestern Siberia.
    AIDS Res Hum Retroviruses. 2021 Mar 7. doi: 10.1089/AID.2020.0225.
    PubMed         Abstract available

  25. SABERI P, Campbell C, Venegas M, Dube K, et al
    Time to Engage Young People in HIV Cure Research.
    AIDS Res Hum Retroviruses. 2021 Mar 7. doi: 10.1089/AID.2020.0268.
    PubMed         Abstract available

  26. BAILEY AJ, Rhee SY, Shafer RW
    Integrase Strand Transfer Inhibitor Resistance in Integrase Strand Transfer Inhibitor-Naive Persons.
    AIDS Res Hum Retroviruses. 2021 Mar 8. doi: 10.1089/AID.2020.0261.
    PubMed         Abstract available

  27. GALAVIZ KI, Schneider MF, Tien PC, Althoff KN, et al
    Expanding the Finnish Diabetes Risk Score for predicting diabetes incidence in people living with HIV.
    AIDS Res Hum Retroviruses. 2021 Mar 8. doi: 10.1089/AID.2020.0247.
    PubMed         Abstract available

  28. HERBERTSON EC, Lahiri C, Nwogu JN, Soremekun RO, et al
    High Acceptability of Donating Hair and other Biological Samples for Research Among People Living with HIV in an Outpatient Clinic in Lagos, Nigeria.
    AIDS Res Hum Retroviruses. 2021 Mar 9. doi: 10.1089/AID.2020.0214.
    PubMed         Abstract available


    Antivir Ther

  29. DORWARD J, Gbinigie O, Cai T, Roberts NW, et al
    The protease inhibitor lopinavir, boosted with ritonavir, as treatment for COVID-19: a rapid review.
    Antivir Ther. 2021 Mar 11. doi: 10.3851/IMP3385.
    PubMed         Abstract available

  30. YIN MT, Bucovsky M, Williams J, Brunjes D, et al
    Effect of Vitamin D3 and calcium carbonate supplementation on muscle strength in postmenopausal women living with HIV.
    Antivir Ther. 2021 Mar 11. doi: 10.3851/IMP3386.
    PubMed         Abstract available


    Blood

  31. SKINNER PJ
    Antigenic cells augment CAR T cells.
    Blood. 2020;136:1701-1702.
    PubMed        

  32. LUZZATTO L, Ally M, Notaro R
    Glucose-6-phosphate dehydrogenase deficiency.
    Blood. 2020;136:1225-1240.
    PubMed         Abstract available


    Clin Infect Dis

  33. YKI-JARVINEN H, Lallukka-Bruck S, Sutinen J
    Reply to Krahn and Sebastiani.
    Clin Infect Dis. 2020;71:245.
    PubMed        

  34. RASMUSSEN TA, Rajdev L, Rhodes A, Dantanarayana A, et al
    Impact of anti-PD-1 and anti-CTLA-4 on the HIV reservoir in people living with HIV with cancer on antiretroviral therapy: The AIDS Malignancy Consortium-095 study.
    Clin Infect Dis. 2021 Mar 2. pii: 6156773. doi: 10.1093/cid/ciaa1530.
    PubMed         Abstract available

  35. ADENIYI OV, Obi CL, Ter Goon D, Iweriebor B, et al
    Factors Associated with Peripartum Virologic Suppression in the Eastern Cape Province, South Africa: A Retrospective Cross-sectional Analysis.
    Clin Infect Dis. 2021 Mar 2. pii: 6157009. doi: 10.1093.
    PubMed         Abstract available

  36. BRAZIER E, Tymejczyk O, Zaniewski E, Egger M, et al
    Effects of national adoption of Treat-All guidelines on pre-ART CD4 testing and viral load monitoring after ART initiation: A regression discontinuity analysis.
    Clin Infect Dis. 2021 Mar 9. pii: 6164944. doi: 10.1093.
    PubMed         Abstract available

  37. LAGROU K, Chen S, Masur H, Viscoli C, et al
    Pneumocystis jirovecii Disease: Basis for the Revised EORTC/MSGERC Invasive Fungal Disease Definitions in Individuals Without Human Immunodeficiency Virus.
    Clin Infect Dis. 2021;72.
    PubMed         Abstract available

  38. MARCONI VC, Moser C, Gavegnano C, Deeks SG, et al
    Randomized Trial of Ruxolitinib in Antiretroviral-Treated Adults with HIV.
    Clin Infect Dis. 2021 Mar 6. pii: 6159796. doi: 10.1093.
    PubMed         Abstract available

  39. CRESSWELL FV, Meya DB, Kagimu E, Grint D, et al
    High-dose oral and intravenous rifampicin for the treatment of tuberculous meningitis in predominantly HIV-positive Ugandan adults: a phase II open-label randomised controlled trial.
    Clin Infect Dis. 2021 Mar 8. pii: 6159697. doi: 10.1093.
    PubMed         Abstract available


    Int J Cancer

  40. CHINULA L, Topazian HM, Mapanje C, Varela A, et al
    Uptake and safety of community-based 'screen-and-treat' with thermal ablation preventive therapy for cervical cancer prevention in rural Lilongwe, Malawi.
    Int J Cancer. 2021 Mar 9. doi: 10.1002/ijc.33549.
    PubMed         Abstract available


    J Infect Dis

  41. WU G, Zuck P, Goh SL, Milush JM, et al
    Gag p24 is a Marker of HIV Expression in Tissues and Correlates with Immune Response.
    J Infect Dis. 2021 Mar 9. pii: 6164924. doi: 10.1093.
    PubMed         Abstract available

  42. MCCREERY RJ, Florescu DF, Kalil AC
    Sepsis in Immunocompromised Patients Without Human Immunodeficiency Virus.
    J Infect Dis. 2020;222.
    PubMed         Abstract available


    J Med Virol

  43. PRZYDZIAL P, Tchomobe G, Amin K, Christian E, et al
    When COVID-19 Crosses Paths with AIDS in the Homeless.
    J Med Virol. 2020 Jul 3. doi: 10.1002/jmv.26255.
    PubMed         Abstract available

  44. OH JJ, Carter JJ, Nemeno JGE, Dix RD, et al
    Parthanatos-associated proteins are stimulated intraocularly during development of experimental murine cytomegalovirus retinitis in mice with retrovirus-induced immunosuppression.
    J Med Virol. 2020;92:394-398.
    PubMed         Abstract available


    J Virol

  45. RANKOVIC S, Deshpande A, Harel S, Aiken C, et al
    HIV-1 uncoating occurs via a series of rapid biomechanical changes in the core related to individual stages of reverse transcription.
    J Virol. 2021 Mar 10. pii: JVI.00166-21. doi: 10.1128/JVI.00166.
    PubMed         Abstract available


    Lancet Infect Dis

  46. VAN DIJCK C, Tsoumanis A, Rotsaert A, Vuylsteke B, et al
    Antibacterial mouthwash to prevent sexually transmitted infections in men who have sex with men taking HIV pre-exposure prophylaxis (PReGo): a randomised, placebo-controlled, crossover trial.
    Lancet Infect Dis. 2021 Mar 4. pii: S1473-3099(20)30778.
    PubMed         Abstract available


    MMWR Morb Mortal Wkly Rep

  47. KOTHEGAL N, Wang A, Jonnalagadda S, MacNeil A, et al
    Screening for HIV Among Patients at Tuberculosis Clinics - Results from Population-Based HIV Impact Assessment Surveys, Malawi, Zambia, and Zimbabwe, 2015-2016.
    MMWR Morb Mortal Wkly Rep. 2021;70:342-345.
    PubMed         Abstract available


    Nature

  48. MAXMEN A
    Achilles heel spotted for promising HIV-prevention drug.
    Nature. 2021 Mar 9. pii: 10.1038/d41586-021-00618.
    PubMed        


    Pediatr Infect Dis J

  49. HIRT D, Kubota Kilengelela J, Jarreau PH, Treluyer JM, et al
    Nevirapine Pharmacokinetics in Neonates Between 25 and 32 Weeks Gestational Age for the Prevention of Mother-to-Child Transmission of HIV.
    Pediatr Infect Dis J. 2021;40:344-346.
    PubMed         Abstract available


    Pediatrics

  50. OSMAN M, du Preez K, Seddon JA, Claassens MM, et al
    Mortality in South African Children and Adolescents Routinely Treated for Tuberculosis.
    Pediatrics. 2021 Mar 10. pii: peds.2020-032490. doi: 10.1542/peds.2020-032490.
    PubMed         Abstract available


    PLoS One

  51. DAUBERT E, Weber KM, French AL, Seidman D, et al
    Obesity is associated with lower bacterial vaginosis prevalence in menopausal but not pre-menopausal women in a retrospective analysis of the Women's Interagency HIV Study.
    PLoS One. 2021;16:e0248136.
    PubMed         Abstract available

  52. BAYARSAIKHAN S, Jagdagsuren D, Gunchin B, Sandag T, et al
    Survival, CD4 T lymphocyte count recovery and immune reconstitution pattern during the first-line combination antiretroviral therapy in patients with HIV-1 infection in Mongolia.
    PLoS One. 2021;16:e0247929.
    PubMed         Abstract available

  53. BITARAKWATE E, Ashburn K, Kazooba P, Khamasi R, et al
    Effects of the Pratt pouch model of dispensing nevirapine prophylaxis on HIV exposed infant completion of 6 weeks of prophylaxis in Uganda.
    PLoS One. 2021;16:e0247507.
    PubMed         Abstract available

  54. SPURNIC AR, Bukumiric Z, Jevtovic D, Brmbolic B, et al
    Helicobacter pylori infection rates in dyspeptic Serbian HIV-infected patients compared to HIV-negative controls.
    PLoS One. 2021;16:e0248041.
    PubMed         Abstract available

  55. NEERUKONDA SN, Vassell R, Herrup R, Liu S, et al
    Establishment of a well-characterized SARS-CoV-2 lentiviral pseudovirus neutralization assay using 293T cells with stable expression of ACE2 and TMPRSS2.
    PLoS One. 2021;16:e0248348.
    PubMed         Abstract available

  56. DE BROUCKER G, Salvatore PP, Mutembo S, Moyo N, et al
    The cost-effectiveness of scaling-up rapid point-of-care testing for early infant diagnosis of HIV in southern Zambia.
    PLoS One. 2021;16:e0248217.
    PubMed         Abstract available

  57. MCINTOSH AT, Wei R, Ahn J, Aouizerat BE, et al
    A genomic variant of ALPK2 is associated with increased liver fibrosis risk in HIV/HCV coinfected women.
    PLoS One. 2021;16:e0247277.
    PubMed         Abstract available

  58. HENKHAUS ME, Hussen SA, Brown DN, Del Rio C, et al
    Barriers and facilitators to use of a mobile HIV care model to re-engage and retain out-of-care people living with HIV in Atlanta, Georgia.
    PLoS One. 2021;16:e0247328.
    PubMed         Abstract available

  59. HAO J, Beld M, Khoddam-Khorasani L, Flentje A, et al
    Comparing substance use and mental health among sexual and gender minority and heterosexual cisgender youth experiencing homelessness.
    PLoS One. 2021;16:e0248077.
    PubMed         Abstract available

  60. SMITH LK, Babcock IW, Minamide LS, Shaw AE, et al
    Direct interaction of HIV gp120 with neuronal CXCR4 and CCR5 receptors induces cofilin-actin rod pathology via a cellular prion protein- and NOX-dependent mechanism.
    PLoS One. 2021;16:e0248309.
    PubMed         Abstract available

  61. LANDES M, van Lettow M, van Oosterhout JJ, Schouten E, et al
    Early post-partum viremia predicts long-term non-suppression of viral load in HIV-positive women on ART in Malawi: Implications for the elimination of infant transmission.
    PLoS One. 2021;16:e0248559.
    PubMed         Abstract available

  62. BELL J, Sharma S, Malone S, Levy M, et al
    Targeting interventions for HIV testing and treatment uptake: An attitudinal and behavioural segmentation of men aged 20-34 in KwaZulu-Natal and Mpumalanga, South Africa.
    PLoS One. 2021;16:e0247483.
    PubMed         Abstract available


    PLoS Pathog

  63. CHEN S, Kumar S, Espada CE, Tirumuru N, et al
    N6-methyladenosine modification of HIV-1 RNA suppresses type-I interferon induction in differentiated monocytic cells and primary macrophages.
    PLoS Pathog. 2021;17:e1009421.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO HIV Infection is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: